{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:56:00Z","timestamp":1778028960979,"version":"3.51.4"},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:sec><jats:title>Background and purpose<\/jats:title><jats:p>Screening batteries to narrow down a target\u2010at\u2010risk population are essential for trials testing neuroprotective compounds aiming to delay or prevent onset of <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>arkinson's disease (<jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The <jats:styled-content style=\"fixed-case\">PRIPS<\/jats:styled-content> study focuses on early detection of incident <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content> in 1847 at baseline <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\u2010free subjects, and assessed age, male gender, positive family history, hyposmia, subtle motor impairment and enlarged substantia nigra hyperechogenicity (<jats:styled-content style=\"fixed-case\">SN<\/jats:styled-content>+).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After 3\u00a0years follow\u2010up 11 subjects had developed <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>. In this analysis of the secondary outcome parameters, sensitivity and specificity of baseline markers for incident <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content> were calculated in 1352 subjects with complete datasets (10 <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content> patients). The best approach for prediction of incident <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content> comprised three steps: (i) prescreening for age, (ii) primary screening for positive family history and\/or hyposmia, and (iii) secondary screening for <jats:styled-content style=\"fixed-case\">SN<\/jats:styled-content>+.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>With this approach, one out of 16 positively screened participants developed <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content> compared to one out of 135 in the original cohort. This corresponds to a sensitivity of 80.0%, a specificity of 90.6% and a positive predictive value of 6.1%. These values are higher than for any single screening instrument but still too low for a feasible and cost\u2010effective screening strategy which might require longer follow\u2010up intervals and application of additional instruments.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1331.2012.03798.x","type":"journal-article","created":{"date-parts":[[2012,8,2]],"date-time":"2012-08-02T00:18:47Z","timestamp":1343866727000},"page":"102-108","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["The <scp>PRIPS<\/scp> study: screening battery for subjects at risk for <scp>P<\/scp>arkinson's disease"],"prefix":"10.1111","volume":"20","author":[{"given":"D.","family":"Berg","sequence":"first","affiliation":[{"name":"Department of Neurodegeneration Hertie Institute for Clinical Brain Research T\u00fcbingen Germany"},{"name":"German Center for Neurodegenerative Diseases T\u00fcbingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Godau","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration Hertie Institute for Clinical Brain Research T\u00fcbingen Germany"},{"name":"German Center for Neurodegenerative Diseases T\u00fcbingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Seppi","sequence":"additional","affiliation":[{"name":"Department of Neurology University of Innsbruck Innsbruck Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Behnke","sequence":"additional","affiliation":[{"name":"Department of Neurology University of Homburg\/Saar Homburg\/Saar Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Liepelt\u2010Scarfone","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration Hertie Institute for Clinical Brain Research T\u00fcbingen Germany"},{"name":"German Center for Neurodegenerative Diseases T\u00fcbingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lerche","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration Hertie Institute for Clinical Brain Research T\u00fcbingen Germany"},{"name":"German Center for Neurodegenerative Diseases T\u00fcbingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Stockner","sequence":"additional","affiliation":[{"name":"Department of Neurology University of Innsbruck Innsbruck Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gaenslen","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration Hertie Institute for Clinical Brain Research T\u00fcbingen Germany"},{"name":"German Center for Neurodegenerative Diseases T\u00fcbingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mahlknecht","sequence":"additional","affiliation":[{"name":"Department of Neurology University of Innsbruck Innsbruck Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Huber","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration Hertie Institute for Clinical Brain Research T\u00fcbingen Germany"},{"name":"German Center for Neurodegenerative Diseases T\u00fcbingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Srulijes","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration Hertie Institute for Clinical Brain Research T\u00fcbingen Germany"},{"name":"German Center for Neurodegenerative Diseases T\u00fcbingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Klenk","sequence":"additional","affiliation":[{"name":"Department of Geriatric Rehabilitation Robert\u2010Bosch\u2010Hospital Stuttgart Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Fassbender","sequence":"additional","affiliation":[{"name":"Department of Neurology University of Homburg\/Saar Homburg\/Saar Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Maetzler","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration Hertie Institute for Clinical Brain Research T\u00fcbingen Germany"},{"name":"German Center for Neurodegenerative Diseases T\u00fcbingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Poewe","sequence":"additional","affiliation":[{"name":"Department of Neurology University of Innsbruck Innsbruck Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the PRIPS study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.66.10_suppl_4.S2","article-title":"The need for neuroprotective therapies in Parkinson's disease: a clinical perspective","volume":"66","author":"Poewe W","year":"2006","journal-title":"Neurology"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21813"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70476-8"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(09)70774-6"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.3.noc50312"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.141"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.174748"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh322"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70216-7"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23114"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70239-4"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348940111001015"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870090112"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.6.1142"},{"key":"e_1_2_6_16_1","first-page":"21430","article-title":"Prevalence of Parkinson's disease in the elderly: the Rotterdam Study","volume":"45","author":"Rijk MC","year":"1995","journal-title":"Neurology"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04013.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200404000-00026"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000149403.14458.7F"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02807.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22719"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1159\/000113682"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2007.03.013"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2012.03798.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2012.03798.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T20:54:21Z","timestamp":1697662461000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2012.03798.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1111\/j.1468-1331.2012.03798.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03798.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"2012-03-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-05-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}